DOI: 10.1186/s12887-023-04259-9; PMCID: PMC10507904
BACKGROUND: Childhood obesity rates have continued to increase with the COVID-19 pandemic. However, data are limited on the impact of increasing obesity on associated comorbidities.
METHODS: We evaluated the progression of overweight- or obesity-associated comorbidities by investigating change in laboratory results pre-COVID-19 pandemic and post-COVID-19 pandemic onset in youth with overweight or obesity. We defined progression of comorbidities based on increase in category rather than absolute change in value.
RESULTS: HbA1c progression was seen in 19%, and LDL cholesterol progression was seen in 26%, as defined by categories. HbA1c progression and LDL cholesterol progression were significantly correlated. HbA1c and LDL cholesterol progression were significantly associated with older age and Hispanics, respectively.
CONCLUSION: The results indicate youths with overweight or obesity have experienced progression of comorbidities during the COVID-19 pandemic. This study emphasizes the importance of early detection of comorbidities among a high-risk pediatric population.
BMC pediatrics [electronic resource]
Child; Adolescent; Humans; Overweight; Cholesterol, LDL; Glycated Hemoglobin; Pandemics; Pediatric Obesity; COVID-19
COVID-19 pandemic; Comorbidities; Obesity; Prediabetes; Youth
Wee E, Sherman AK, Farrukh S, Clements MA, Halpin K, Yan Y. Progression of comorbidities in youth with overweight or obesity during the COVID-19 pandemic. BMC Pediatr. 2023;23(1):471. Published 2023 Sep 19. doi:10.1186/s12887-023-04259-9